The effect of muscle energy technique and ischemic compression in the treatment of cervicogenic headaches: combination mode versus single mode
- Conditions
- Musculoskeletal Diseases
- Registration Number
- PACTR202402802373266
- Lead Sponsor
- A
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 45
•Participants must be between the ages of 18 and 55 years (verified by identification) as individuals in between those years are more likely to suffer from MPS (Simons et al. 1999; Barbero et al. 2019; Li et al. 2020). These statistics would support the current age group limits set for this study. The mean age for the CGH condition is 42.9 years, but it varies from 20 to 60 (Park et al. 2021).
•It is preferable that participants are conversant and literate in English.
•Participants were only accepted once they have read and signed the Informed Consent form and had undergone a complete case history and physical examination.
•Participants must meet a minimum of three diagnostic criteria listed below to qualify for the research study (Sjaastad and Fredriksen 2000). These criteria were evaluated on the participant by the researcher and clinician on duty.
oUnilateral headache with no side shift
oAggravation of headache by sustained awkward head position, neck movement or external pressure on the occipital area or upper cervical area on the symptomatic side.
oDecreased range of motion or spinal facet restriction in the cervical spine.
oIpsilateral non-radicular head, neck, or shoulder pain.
The International Headache Society criteria for the diagnostic test for CGH was not used in this study because it needed to use a diagnostic nerve block and was impractical for the setting of this study.
•Participants that do not sign the informed consent form (Appendix C) or refuse to undergo case history and physical examination.
•Participants that are unable to commit to the full study duration.
•Participants that have any contra-indications to MET including hypermobility, the fragility of tissue, myositis, and tumours (Chaitow and Crenshaw, 2006; Ferna´ndez-de-las-Pen~as, Cleland and Huijbregts, 2011).
•Participant who has taken any medication or received any other treatment in the 24 hours prior to the initial consultation and duration of the study.
•Participants with neck or shoulder pain caused by reasons other than CGH. This was determined during the first consultation.
•Participants receiving any other cervical manipulative treatment for the CGH.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome measurement would be the pain pressure threshold.
- Secondary Outcome Measures
Name Time Method cervical range of motion measurement